Abstract
In this Practice Point commentary, we discuss Wiggins et al.'s systematic review of the treatment of peritonitis, a serious problem in peritoneal dialysis patients. Wiggins and co-workers reported that most antibiotic classes were similarly effective for the treatment of peritonitis. Despite the limited data available, the investigators found that the intraperitoneal route was more effective than the intravenous route in preventing treatment failure, that intermittent dosing of various antibiotics was as effective as continuous administration of these drugs, and that glycopeptide-based regimens were more likely than first-generation cephalosporins to achieve a complete cure. Here, we discuss the importance of treating peritonitis and the lack of and limitations of existing data, and emphasize the urgent need for well-designed, large randomized trials in this area.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Wiggins KJ et al. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD005284. 10.1002/14651858.CD005284.pub2
Piraino B et al. (2005) Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 25: 107–131
Fried LF et al. (1996) Peritonitis influences mortality in peritoneal dialysis patients. J Am Soc Nephrol 7: 2176–2182
US Renal Data System (2004) USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases
Gupta B et al. (1996) Peritonitis associated with exit site and tunnel infections. Am J Kidney Dis 28: 415–419
Coban E et al. (2004) The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis. J Nephrol 17: 427–430
Pagniez DC et al. (1988) Withdrawal of continuous ambulatory peritoneal dialysis to treat mild peritonitis. BMJ 297: 1174–1175
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
B Piraino has declared an association with the following company: Baxter Healthcare (Consultant). F Bender declared no competing interests.
Rights and permissions
About this article
Cite this article
Piraino, B., Bender, F. How should peritoneal-dialysis-associated peritonitis be treated?. Nat Rev Nephrol 4, 356–357 (2008). https://doi.org/10.1038/ncpneph0831
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneph0831